Inhibition of inducible nitric oxide synthase protects against the deleterious effects of sub-lethal sepsis and ethanol in the cardiorenal system

Can J Physiol Pharmacol. 2021 Dec;99(12):1324-1332. doi: 10.1139/cjpp-2021-0239. Epub 2021 Jul 27.

Abstract

We tested the hypothesis that ethanol would aggravate the deleterious effects of sub-lethal cecal ligation and puncture (SL-CLP) sepsis in the cardiorenal system and that inhibition of inducible nitric oxide synthase (iNOS) would prevent such response. Male C57BL/6 mice were treated with ethanol for 12 weeks. One hour before SL-CLP surgery, mice were treated with N6-(1-iminoethyl)-lysine (L-NIL, 5 mg/kg, i.p.), a selective inhibitor of iNOS. A second dose of L-NIL was administered 24 h after SL-CLP surgery. Mice were killed 48 h post surgery and the blood, the renal cortex, and the left ventricle (LV) were collected for biochemical analysis. L-NIL attenuated the increase in serum creatinine levels induced by ethanol, but not by SL-CLP. Ethanol, but not SL-CLP, increased creatine kinase (CK)-MB activity and L-NIL did not prevent this response. In the renal cortex, L-NIL prevented the redox imbalance induced by ethanol and SL-CLP. Inhibition of iNOS also decreased lipoperoxidation induced by ethanol and SL-CLP in the LV. L-NIL prevented the increase of pro-inflammatory cytokines and reactive oxygen species induced by ethanol and (or) SL-CLP in the cardiorenal system, suggesting that iNOS modulated some of the molecular mechanisms that underlie the deleterious effects of both conditions in the cardiorenal system.

Keywords: cardiac; cytokines; cœur; déséquilibre redox; kidney; oxidative stress; redox imbalance; reins; stress oxydatif.

MeSH terms

  • Animals
  • Creatine Kinase, MB Form / metabolism
  • Creatinine / blood
  • Cytokines / metabolism
  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / pharmacology*
  • Ethanol / adverse effects*
  • Heart Ventricles / metabolism*
  • Inflammation Mediators / metabolism
  • Kidney Cortex / metabolism*
  • Lipid Peroxidation / drug effects
  • Lysine / administration & dosage
  • Lysine / pharmacology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nitric Oxide Synthase Type II / antagonists & inhibitors*
  • Nitric Oxide Synthase Type II / physiology
  • Reactive Oxygen Species / metabolism
  • Sepsis / etiology*
  • Sepsis / prevention & control*

Substances

  • Cytokines
  • Enzyme Inhibitors
  • Inflammation Mediators
  • Reactive Oxygen Species
  • Ethanol
  • Creatinine
  • Nitric Oxide Synthase Type II
  • Creatine Kinase, MB Form
  • Lysine